Trials / Conditions / PD-1 Immunotherapy

PD-1 Immunotherapy

3 registered clinical trials studyying PD-1 Immunotherapy — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Can NCT06485271	Changzhi People's Hospital Affiliated to Changzhi Medical College	—
Unknown	PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery NCT05468138	Fudan University	Phase 2
Unknown	Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma NCT05265793	Fudan University	Phase 2